DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (38)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 38   Next >>

Possible Depakene side effects in 34 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27

Patient: 34 year old male

Reactions: Intestinal Ischaemia, Ileus, Gastrointestinal Necrosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01
    End date: 2012-06-25

Lepticur
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-05
    End date: 2012-06-25

Loxapine HCL
    Dosage: 275 drops daily
    Administration route: Oral
    Indication: Aggression
    Start date: 2012-06-14
    End date: 2012-06-25

Quetiapine
    Dosage: daily
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-06-05
    End date: 2012-06-25

Valium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-01
    End date: 2012-06-25



Possible Depakene side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Multi-Organ Failure, Diarrhoea, Acute Respiratory Distress Syndrome, Hepatorenal Failure, Drug Rash With Eosinophilia and Systemic Symptoms, Convulsion, Disease Progression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2006-11-11
    End date: 2009-09-07

Phenytoin Sodium CAP
    Indication: Status Epilepticus
    Start date: 2009-06-25
    End date: 2009-09-07

Tegretol
    Administration route: Oral
    Indication: Status Epilepticus
    Start date: 2009-06-25
    End date: 2009-09-07

Temodal
    Dosage: 150 mg/m2, qd
    Administration route: Oral
    Start date: 2010-06-11
    End date: 2010-10-05

Temodal
    Administration route: Oral
    Start date: 2008-02-21
    End date: 2008-02-25

Temodal
    Dosage: 150 mg/m2, qd
    Administration route: Oral
    Start date: 2009-09-28
    End date: 2010-05-04

Temodal
    Administration route: Oral
    Start date: 2007-11-29
    End date: 2007-12-03

Temodal
    Administration route: Oral
    Start date: 2008-04-17
    End date: 2008-04-21

Temodal
    Administration route: Oral
    Start date: 2008-10-02
    End date: 2008-10-06

Temodal
    Administration route: Oral
    Start date: 2008-10-30
    End date: 2008-11-03

Temodal
    Administration route: Oral
    Start date: 2010-02-08
    End date: 2010-02-12

Temodal
    Administration route: Oral
    Start date: 2010-03-08
    End date: 2010-03-12

Temodal
    Administration route: Oral
    Start date: 2010-06-11
    End date: 2010-06-15

Temodal
    Dosage: 150 mg/m2, qd
    Administration route: Oral
    Start date: 2007-01-25
    End date: 2009-05-18

Temodal
    Administration route: Oral
    Start date: 2007-03-22
    End date: 2007-03-26

Temodal
    Administration route: Oral
    Start date: 2007-06-14
    End date: 2007-06-18

Temodal
    Administration route: Oral
    Start date: 2007-08-09
    End date: 2007-08-13

Temodal
    Administration route: Oral
    Start date: 2007-10-04
    End date: 2007-10-08

Temodal
    Administration route: Oral
    Start date: 2009-12-14
    End date: 2009-12-18

Temodal
    Administration route: Oral
    Start date: 2008-05-15
    End date: 2008-05-19

Temodal
    Administration route: Oral
    Start date: 2009-10-26
    End date: 2009-10-30

Temodal
    Dosage: 75 mg/m2, qd
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2006-11-28
    End date: 2006-12-26

Temodal
    Administration route: Oral
    Start date: 2007-02-22
    End date: 2007-02-26

Temodal
    Administration route: Oral
    Start date: 2007-11-01
    End date: 2007-11-05

Temodal
    Administration route: Oral
    Start date: 2008-03-20
    End date: 2008-03-24

Temodal
    Administration route: Oral
    Start date: 2008-07-10
    End date: 2008-07-14

Temodal
    Administration route: Oral
    Start date: 2009-01-22
    End date: 2009-01-26

Temodal
    Administration route: Oral
    Start date: 2009-04-16
    End date: 2009-04-20

Temodal
    Administration route: Oral
    Start date: 2010-01-11
    End date: 2010-01-15

Temodal
    Administration route: Oral
    Start date: 2010-07-09
    End date: 2010-07-13

Temodal
    Administration route: Oral
    Start date: 2010-09-03
    End date: 2010-09-07

Temodal
    Administration route: Oral
    Start date: 2007-01-25
    End date: 2007-01-29

Temodal
    Administration route: Oral
    Start date: 2007-09-06
    End date: 2007-09-10

Temodal
    Administration route: Oral
    Start date: 2007-12-27
    End date: 2007-12-31

Temodal
    Administration route: Oral
    Start date: 2008-01-24
    End date: 2008-01-28

Temodal
    Administration route: Oral
    Start date: 2008-08-07
    End date: 2008-08-11

Temodal
    Administration route: Oral
    Start date: 2009-03-19
    End date: 2009-03-23

Temodal
    Administration route: Oral
    Start date: 2010-05-03
    End date: 2010-05-04

Temodal
    Administration route: Oral
    Start date: 2007-04-19
    End date: 2007-04-23

Temodal
    Administration route: Oral
    Start date: 2007-05-17
    End date: 2007-05-21

Temodal
    Administration route: Oral
    Start date: 2007-07-12
    End date: 2007-07-16

Temodal
    Administration route: Oral
    Start date: 2008-09-04
    End date: 2008-09-08

Temodal
    Administration route: Oral
    Start date: 2008-11-28
    End date: 2008-12-02

Temodal
    Administration route: Oral
    Start date: 2008-12-25
    End date: 2008-12-29

Temodal
    Administration route: Oral
    Start date: 2009-02-19
    End date: 2009-02-23

Temodal
    Administration route: Oral
    Start date: 2009-05-14
    End date: 2009-05-18

Temodal
    Administration route: Oral
    Start date: 2009-09-28
    End date: 2009-10-02

Temodal
    Administration route: Oral
    Start date: 2010-04-05
    End date: 2010-04-09

Temodal
    Administration route: Oral
    Start date: 2008-06-12
    End date: 2008-06-16

Temodal
    Administration route: Oral
    Start date: 2010-08-06
    End date: 2010-08-10

Temodal
    Administration route: Oral
    Start date: 2010-10-01
    End date: 2010-10-05

Other drugs received by patient: Depakene; Phenobarbital TAB; Betamethasone Sodium Phosphate; Kytril; Zonisamide; Diprivan; Isozol; Topiramate; Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Streptococcus Faec



Possible Depakene side effects in 34 year old male

Reported by a physician from France on 2012-08-22

Patient: 34 year old male

Reactions: Intestinal Ischaemia, Gastrointestinal Necrosis, Intestinal Obstruction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-06-25

Lepticur
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-05
    End date: 2012-06-25

Loxapine HCL
    Administration route: Oral
    Indication: Aggression
    Start date: 2012-06-14
    End date: 2012-06-25

Quetiapine Fumarate
    Dosage: drug reported as xeroquel
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-06-05
    End date: 2012-06-25

Valium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-06-25



Possible Depakene side effects in 75 year old male

Reported by a physician from Japan on 2012-08-07

Patient: 75 year old male

Reactions: Thrombocytopenia, Cerebrovascular Accident

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene
    Dosage: daily dose: 2 g
    Administration route: Oral

Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-15
    End date: 2011-10-20

Lamictal
    Dosage: daily dose: 100 mg
    Administration route: Oral



Possible Depakene side effects in 75 year old male

Reported by a physician from Japan on 2012-08-07

Patient: 75 year old male

Reactions: Cerebrovascular Accident, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene
    Dosage: daily dose: 2 g
    Administration route: Oral

Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-15
    End date: 2011-10-20

Lamictal
    Dosage: daily dose: 100 mg
    Administration route: Oral



Possible Depakene side effects in 16 year old female

Reported by a health professional (non-physician/pharmacist) from Cameroon on 2012-08-06

Patient: 16 year old female

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20

Patient: female

Reactions: Foetal Growth Restriction, Premature Baby, Foetal Exposure During Pregnancy, Congenital Teratoma

Adverse event resulted in: death

Drug(s) suspected as cause:
Clobazam
    Dosage: 5 mg in the morning and 10 mg in the evening
    Start date: 2009-02-01
    End date: 2009-03-01

Clobazam
    Start date: 2009-03-01
    End date: 2009-03-31

Clobazam
    End date: 2009-02-01

Depakene
    End date: 2009-03-31

Keppra
    End date: 2009-03-01

Keppra
    Start date: 2009-03-01
    End date: 2009-03-31



Possible Depakene side effects in 54 year old female

Reported by a physician from China on 2012-06-12

Patient: 54 year old female

Reactions: Drug Interaction, Status Epilepticus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient possibly interacting with the suspect drug:
Phenobarbital TAB
    Administration route: Oral
    Indication: Epilepsy

Phenobarbital TAB
    Administration route: Oral
    Start date: 2012-05-20
    End date: 2012-05-22

Sodium Bromide
    Administration route: Oral
    Indication: Epilepsy

Sodium Bromide
    Administration route: Oral
    Start date: 2012-05-20
    End date: 2012-05-22



Possible Depakene side effects in 54 year old female

Reported by a consumer/non-health professional from China on 2012-06-08

Patient: 54 year old female

Reactions: Drug Interaction, Status Epilepticus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene

Other drugs received by patient possibly interacting with the suspect drug:
Phenobarbital TAB
    Administration route: Oral
    Indication: Epilepsy

Phenobarbital TAB
    Administration route: Oral
    Start date: 2012-05-20
    End date: 2012-05-22

Sodium Bromide
    Administration route: Oral
    Start date: 2012-05-20
    End date: 2012-05-22

Sodium Bromide
    Administration route: Oral
    Indication: Epilepsy



Possible Depakene side effects in

Reported by a consumer/non-health professional from Brazil on 2012-06-04

Patient:

Reactions: Ultrasound Scan Abnormal, Dandy-Walker Syndrome, Foetal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in

Reported by a consumer/non-health professional from Brazil on 2012-06-01

Patient:

Reactions: Dandy-Walker Syndrome, Foetal Exposure During Pregnancy

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-01

Patient:

Reactions: Foetal Anticonvulsant Syndrome, Congenital Hand Malformation, Foetal Exposure During Pregnancy, Exomphalos, Limb Malformation, Neck Deformity, Talipes, Abortion Induced, Foetal Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in 42 year old male

Reported by a physician from Japan on 2012-04-18

Patient: 42 year old male, weighing 84.0 kg (184.8 pounds)

Reactions: Glioblastoma Multiforme, Hepatorenal Failure, Neoplasm Progression, Status Epilepticus, Drug Rash With Eosinophilia and Systemic Symptoms, Multi-Organ Failure, Diarrhoea, Acute Respiratory Distress Syndrome

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Depakene
    Dosage: po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2006-11-11
    End date: 2009-09-07

Phenytoin
    Indication: Status Epilepticus
    Start date: 2009-06-25
    End date: 2009-09-07

Tegretol
    Dosage: po
    Administration route: Oral
    Indication: Status Epilepticus
    Start date: 2009-06-25
    End date: 2009-09-07

Temodal
    Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2009-09-28
    End date: 2010-05-04

Temodal
    Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-11
    End date: 2010-10-05

Temodal
    Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2007-01-25
    End date: 2009-05-18

Temodal
    Dosage: 75 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po, 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2006-11-28
    End date: 2006-12-26

Other drugs received by patient: Kytril / 01178102 /; Zonisamide; Isozol; Topina (Topiramate); Phenobarbital TAB; Diprivan; Biofermin (Lactomin)



Possible Depakene side effects in 70 year old male

Reported by a physician from Japan on 2012-04-05

Patient: 70 year old male

Reactions: Death, Pancytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-07
    End date: 2011-12-13

Keppra
    Dosage: 1000mg per day
    Administration route: Oral
    Indication: Convulsion
    Start date: 2011-12-07
    End date: 2011-12-18

Lamictal
    Administration route: Oral
    Start date: 2011-12-28
    End date: 2012-02-13

Lamictal
    Dosage: 50mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-12-18
    End date: 2011-12-27

Temodal
    Indication: Brain Neoplasm



Possible Depakene side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-03-28

Patient: 30 year old female, weighing 63.0 kg (138.6 pounds)

Reactions: Death, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clozaril
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2000-12-28
    End date: 2012-02-05

Depakene
    Dosage: 1 at bedtime
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2003-11-19
    End date: 2012-02-05

Depakene
    Indication: Affective Disorder

Other drugs received by patient: Gemfibrozil; Sennapur; Halin; Magnesium Oxide



Possible Depakene side effects in

Reported by a physician from Egypt on 2012-03-23

Patient:

Reactions: Caesarean Section, Haemorrhage, Foetal Exposure During Pregnancy, Sepsis, Hypoxia, Encephalitic Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in

Reported by a physician from France on 2012-03-08

Patient:

Reactions: Spina Bifida, Foetal Exposure During Pregnancy, Abortion Induced

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-03-01

Patient: 30 year old female

Reactions: Death, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clozaril
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2000-12-28
    End date: 2012-02-05

Depakene
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2003-11-19
    End date: 2012-02-05

Other drugs received by patient: Gemfibrozil; Halin; Magnesium Oxide; Sennapur



Possible Depakene side effects in

Reported by a pharmacist from Taiwan, Province of China on 2012-02-29

Patient:

Reactions: Abdominal Pain, Gastrointestinal Motility Disorder, Dyspnoea, Urinary Tract Infection, Ileus, Heart Rate Increased, Sepsis, Liver Function Test Abnormal, Tenderness, Blood Pressure Decreased, White Blood Cell Count Increased, Blood Glucose Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Clozaril
    Dosage: 100mg/pill, range from 25mg to 1200mg
    Indication: Mental Disorder
    Start date: 2000-12-28
    End date: 2012-02-05

Depakene
    Dosage: dose:200mg/pill, 500mg/pill, (range from 200mg to 2400mg)
    Indication: Mental Disorder
    Start date: 2003-11-19
    End date: 2012-02-05

Other drugs received by patient: Haloperidol



Possible Depakene side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-02-17

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Confusional State, Pneumonia, Diabetic Complication, Secretion Discharge, Somnolence, Speech Disorder, Blood Glucose Decreased, Eyelid Function Disorder, Tongue Disorder

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Diazepam; Captopril; Haloperidol; Nortriptyline HCL; Insulin



Possible Depakene side effects in male

Reported by a pharmacist from Japan on 2012-02-15

Patient: male, weighing 64.6 kg (142.1 pounds)

Reactions: Nervous System Disorder, Disorientation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: 200 mg, bid
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2007-10-01
    End date: 2011-11-20

Fentanyl-100
    Dosage: 0.4 mg, qod
    Start date: 2011-11-15
    End date: 2011-11-16

Fentanyl-100
    Dosage: 0.2 mg, qod
    Start date: 2011-11-14
    End date: 2011-11-14

Fentanyl-100
    Dosage: 0.1 mg, qod
    Indication: Pain
    Start date: 2011-11-12
    End date: 2011-11-13

Fentanyl-100
    Dosage: unk
    Start date: 2011-11-17
    End date: 2011-11-23

Prograf
    Dosage: 0.155 mg, uid/qd
    Start date: 2011-11-14
    End date: 2011-11-20

Prograf
    Dosage: 0.31 mg, uid/qd
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-11-10
    End date: 2011-11-13

Prograf
    Dosage: unk
    Start date: 2011-11-21
    End date: 2011-11-23

Other drugs received by patient: Famotidine; Funguard; Methotrexate; Vitamedin; Ubiron; Ceftazidime; Filgrastim; Pantosin; Pentazocine Lactate; Acyclovir; Glycyron; Lendormin; Magmitt; Teicoplanin



Possible Depakene side effects in 18 year old male

Reported by a consumer/non-health professional from Italy on 2012-01-30

Patient: 18 year old male, weighing 100.0 kg (220.0 pounds)

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Depakene
    Dosage: 6 dosage form; daily
    Administration route: Oral
    Indication: Epilepsy

Frisium
    Dosage: 3 dosage form: daily
    Administration route: Oral
    Indication: Epilepsy



Possible Depakene side effects in 85 year old male

Reported by a physician from Poland on 2012-01-13

Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Death, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abilify
    Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10

Depakene
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10

Lamotrigine
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10



Possible Depakene side effects in 17 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: 17 year old female

Reactions: Multi-Organ Failure, Agranulocytosis, Histiocytosis Haematophagic, Condition Aggravated, Pancytopenia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amikacin
    Dosage: unk
    Indication: Escherichia Bacteraemia
    Start date: 2008-12-25

Cyclophosphamide
    Dosage: 750.0 mg, 1x/cyc
    Indication: Sjogren's Syndrome
    Start date: 2008-12-25

Depakene
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-26

Diprivan
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-18

Fosphenytoin Sodium
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-09
    End date: 2008-12-01

Keppra
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-06

Pantoprazole Sodium
    Dosage: unk
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2008-12-01

Pentothal
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-08

Phenobarbital TAB
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-01

Piperacillin and Tazobactam
    Dosage: unk
    Indication: Escherichia Bacteraemia
    Start date: 2008-12-25

Sufenta Preservative Free
    Dosage: unk
    Indication: Sedation
    Start date: 2008-11-29
    End date: 2008-12-25

Urbanyl
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-15

Vancomycin HCL
    Dosage: unk
    Indication: Pneumonia Staphylococcal
    Start date: 2008-12-01

Other drugs received by patient: Paracetamol; Neostigmine; Duphalac; Solu-Medrol; Norepinephrine; Neupogen



Possible Depakene side effects in 17 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: 17 year old female

Reactions: Multi-Organ Failure, Histiocytosis Haematophagic, Agranulocytosis, Pancytopenia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amikacin
    Dosage: unk
    Indication: Escherichia Infection
    Start date: 2008-12-25

Cyclophosphamide
    Dosage: 750 mg
    Indication: Sjogren's Syndrome
    Start date: 2008-12-11

Depakene
    Dosage: unk
    Indication: Epilepsy
    Start date: 2008-12-26

Diprivan
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-18

Fosphenytoin Sodium
    Dosage: 750 mg, cyclic
    Indication: Epilepsy
    Start date: 2008-12-11
    End date: 2008-12-01

Keppra
    Dosage: unk
    Indication: Epilepsy
    Start date: 2008-12-06

Pantoprazole Sodium
    Dosage: unk
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2008-12-01

Pentothal
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-08

Phenobarbital TAB
    Dosage: unk
    Indication: Epilepsy
    Start date: 2008-12-01

Piperacillin and Tazobactam
    Dosage: unk
    Indication: Escherichia Infection
    Start date: 2008-12-25

Sufenta Preservative Free
    Dosage: unk
    Indication: Sedation
    Start date: 2008-11-29
    End date: 2008-12-25

Urbanyl
    Dosage: unk
    Indication: Epilepsy
    Start date: 2008-12-15

Vancomycin HCL
    Dosage: unk
    Indication: Pneumonia Staphylococcal
    Start date: 2008-12-01

Other drugs received by patient: Duphalac; Neostigmine Bromide; Aciclovir; Neupogen; Norepinephrine Bitartrate; Claforan; Solu-Medrol; Paracetamol



Possible Depakene side effects in 42 year old male

Reported by a physician from Japan on 2012-01-05

Patient: 42 year old male, weighing 84.0 kg (184.8 pounds)

Reactions: Diarrhoea, Status Epilepticus, Apparent Life Threatening Event, Drug Rash With Eosinophilia and Systemic Symptoms, Disease Progression

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2006-11-11

Phenytoin
    Dosage: indrp
    Indication: Status Epilepticus
    Start date: 2009-06-25

Tegretol
    Dosage: po
    Administration route: Oral
    Indication: Status Epilepticus
    Start date: 2009-06-25

Temodal
    Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2006-11-28
    End date: 2006-12-26

Temodal
    Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2007-01-25
    End date: 2009-05-18

Temodal
    Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2009-09-28
    End date: 2010-05-04

Temodal
    Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po
    Administration route: Oral
    Indication: Glioblastoma Multiforme
    Start date: 2010-06-11
    End date: 2010-10-05

Other drugs received by patient: Kytril / 01178102 /



Possible Depakene side effects in 20 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-04

Patient: 20 year old female

Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Drug Screen Positive, Nausea, Hepatic Failure, Prothrombin Time Prolonged, Headache, Hepatitis, Convulsion, Hepatic Steatosis, Haemoglobin Decreased, Diarrhoea, Hepatitis Fulminant, Cough, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Dosage: dose decreased
    Start date: 2005-01-24
    End date: 2005-02-04

Depakene
    Administration route: Oral
    Indication: Myoclonic Epilepsy
    Start date: 2004-10-30
    End date: 2005-01-23

Gestodene and Ethinyl Estradiol
    Dosage: 1 unit daily
    Administration route: Oral
    Indication: Contraception
    Start date: 2004-01-01

Urbanyl
    Administration route: Oral
    Indication: Myoclonic Epilepsy
    Start date: 2004-10-30
    End date: 2005-02-04

Other drugs received by patient: Gestodene and Ethinyl Estradiol



Possible Depakene side effects in 85 year old male

Reported by a physician from Poland on 2011-12-20

Patient: 85 year old male, weighing 85.0 kg (187.0 pounds)

Reactions: Death, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Abilify
    Dosage: 15 mg in the morning and 15 mg in the evening last dose:15mg in mrng
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10

Depakene
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10

Lamotrigine
    Indication: Schizophrenia, Paranoid Type
    Start date: 2011-11-03
    End date: 2011-12-10



Possible Depakene side effects in 20 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-12-20

Patient: 20 year old female

Reactions: Blood Bilirubin Increased, Hepatic Necrosis, Drug Screen Positive, Nausea, Hepatic Failure, Headache, Prothrombin Time Prolonged, Hepatitis, Convulsion, Hepatic Steatosis, Haemoglobin Decreased, Diarrhoea, Hepatitis Fulminant, Cough, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Myoclonic Epilepsy
    Start date: 2004-10-30
    End date: 2005-01-23

Depakene
    Dosage: dose decreased
    Start date: 2005-01-24
    End date: 2005-02-04

Gestodene and Ethinyl Estradiol
    Dosage: 1 unit daily
    Administration route: Oral
    Indication: Contraception
    Start date: 2004-01-01

Urbanyl
    Administration route: Oral
    Indication: Myoclonic Epilepsy
    Start date: 2004-10-30
    End date: 2005-02-04

Other drugs received by patient: Gestodene and Ethinyl Estradiol



Possible Depakene side effects in 65 year old male

Reported by a physician from France on 2011-12-16

Patient: 65 year old male

Reactions: Disseminated Intravascular Coagulation, Cholestasis, Stevens-Johnson Syndrome

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Depakene
    Administration route: Oral
    Indication: Epilepsy
    End date: 2011-11-05

Lamictal
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-10-12
    End date: 2011-11-05



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017